Clarus (CLAR) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
15 Nov, 2025Executive summary
Q3 2025 sales increased 3–3.3% year-over-year to $69.3 million, led by 16% Adventure segment growth and offset by a 1% Outdoor segment decline due to the PIEPS divestiture and lower DTC revenue.
Adjusted EBITDA rose 15% to $2.8 million (4.0% margin), with Outdoor contributing $4.7 million and Adventure $349,000–$400,000.
Net loss narrowed to $1.6 million ($0.04 per share), improved from $3.2 million loss in the prior year; adjusted net income was $1.8 million ($0.05 per share), flat year-over-year.
Organizational restructuring, SKU rationalization, and cost controls improved profitability and inventory quality.
Adventure segment growth was driven by new customers, strong Australia wholesale, and the RockyMounts acquisition.
Financial highlights
Gross margin was 35.1%, nearly flat year-over-year; adjusted gross margin declined from 37.8% to 35.1%.
SG&A expenses decreased 6–6.2% to $26.2 million, reflecting cost controls and the PIEPS sale.
Free cash flow for Q3 was negative $6.9–$7.0 million; cash at quarter-end was $29.5 million, with $2.0 million in debt.
Net cash used in operating activities was $5.7 million, improved from $8.3 million in the prior year quarter.
Net loss per share for Q3 was $(0.04), improved from $(0.08) in the prior year.
Outlook and guidance
No formal quantitative guidance for 2025 due to macroeconomic and trade uncertainties.
Management expects to generate free cash flow in Q4 and end the year with $35–$40 million in cash.
Ongoing restructuring and cost reduction actions are expected to continue through year-end 2025.
Second round of tariff mitigation actions planned for 2026 to offset $3.2 million in unmitigated tariff impact.
Liquidity needs for the next 12 months are expected to be met through operating cash flows and asset sale proceeds.
Latest events from Clarus
- 2025 sales and margins fell, but 2026 guidance targets EBITDA growth and debt-free stability.CLAR
Q4 20255 Mar 2026 - Q2 sales fell, margins compressed, but cash surged and guidance was adjusted after asset sales.CLAR
Q2 20242 Feb 2026 - Q3 sales dropped 17.4%, losses widened, but gross margin and cash position improved.CLAR
Q3 202415 Jan 2026 - 2024 saw lower sales but improved margins and cash flow; 2025 outlook expects growth amid risks.CLAR
Q4 202418 Dec 2025 - Key votes include director elections, auditor ratification, and a new stock incentive plan.CLAR
Proxy Filing1 Dec 2025 - Proxy supplement outlines major changes to the stock incentive plan and new proxy solicitor.CLAR
Proxy Filing1 Dec 2025 - Q1 sales dropped 13% and guidance was withdrawn amid macro and tariff uncertainty.CLAR
Q1 202521 Nov 2025 - Q2 sales fell 2%, net loss widened, and PIEPS divestiture advanced business simplification.CLAR
Q2 202516 Nov 2025